Experimental Type 1 Diabetes Drug Shields Pancreas Cells from the Usual Crippling Immune System Attack

[[{“value”:”

Scientists at Johns Hopkins have found that an experimental antibody drug can prevent and reverse type 1 diabetes, and often extend the lives of mice. Researchers say that the drug mAb43 targets insulin-producing beta cells directly in the pancreas and is designed to shield these cells from […]
The post Experimental Type 1 Diabetes Drug Protects Pancreas cells from the Usual Crippling immune system Attack appeared first on Good News Network.

“}]] Researchers at Johns Hopkins claim that an exploratory antibody drug can frequently lengthen people’s lives and stop mice from developing type 1 diabetes. The researchers claim that the drug mAb43 is special because it directly targets insulin-producing beta cells in the pancreas and is intended to protect those cells from injury.
On Good News Network, the article Experimental Type 1 Diabetes Drug Shields Pancreas Cells from the Common Crippling Immune System Attack first appeared.